Notice of Intent Roche Magna Pure 96

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Roche Diagnostics for Roche MagNaPure 96 . The Roche MagNA Pure 96 is a benchtop automated nucleic acid extraction instrument that has a relatively small footprint (53.9” x 31.5” x 39.4”) that can process up to 96 reactions per run. This instrument utilizes magnetic bead technology (instead of centrifugation) and has an on-board UV lamp; both of these considerations are required to minimize cross-contaminations during and between runs. Roche is the only manufacturer that has software pre-programmed with dedicated purification protocols for the MagNa Pure 96 DNA and Viral nucleic acid small volume kit. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 41 U.S.C. 3304(a)(1).. Interested persons may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent is not a request for competitive quotations; however, all quotations/responses received within five (5) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to William Brannen at [email protected] by 2:00 P.M. EST., July 8, 2022.